The mitochondrial Ca 2+ uniporter (MCU) complex mediates acute mitochondrial Ca 2+ influx.
Introduction
In skeletal muscle Ca 2+ directly mediates excitation-contraction coupling as well as stimulating mitochondrial energy production. Within the myofiber, mitochondria and the sarcoplasmic reticulum (SR) are tethered together whereby SR Ca 2+ release directly augments mitochondrial Ca 2+ influx for contraction-metabolic coupling (1) . Mitochondrial Ca 2+ influx serves as a rapid signal for the allosteric activation of select matrix dehydrogenases of the tricarboxylic acid (TCA) cycle, as well as the mitochondrial ATP synthase, to collectively enhance energy output (2, 3) .
The mitochondrial Ca 2+ uniporter (MCU) complex comprises a central Ca 2+ -transducing pore made of MCU multimers (4, 5) and regulatory elements, including MICU1, MICU2, EMRE, SLC25a23, and MCUb (6) (7) (8) (9) (10) (11) , which facilitates the voltage-dependent import of Ca 2+ into the mitochondrial matrix (12) . Recent studies using mouse models of both global deletion and targeted cardiac-specific deletion of Mcu show its importance in mediating mitochondrial Ca 2+ import and mitochondrial energy production (13) (14) (15) . However, the MCU complex appears to preferentially regulate acute mitochondrial Ca 2+ influx, such as with the fight-or-flight response. For example, cardiac-specific deletion of Mcu in mice showed that mitochondria still loaded with Ca 2+ in the long term and that only acute modes of Ca 2+ influx and metabolic coupling were compromised (14) . Indeed, with prolonged stimulation, Mcu-deficient cardiomyocytes and hearts no longer showed a defect in mitochondrial respiration augmentation (14) .
There is evidence that the MCU plays a role in skeletal muscle growth and homeostasis. For example, global Mcu gene-deleted mice are growth retarded and show constitutive inhibition of the pyruvate dehydrogenase complex in skeletal muscle (13) . MCU was also suggested to directly regulate cellular growth
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pathways because viral-mediated overexpression of MCU in young mice caused muscle hypertrophy, whereas viral-mediated shRNA knock down caused atrophy (16) . These studies link MCU to metabolism and growth in skeletal muscle.
Here, we investigated the role of MCU in skeletal muscle development and function using mice with skeletal muscle-specific deletion of the Mcu gene initiated at embryonic, postnatal, and adult stages. We show that while deletion of Mcu did not alter skeletal muscle growth, it did alter metabolic substrate preference with enhanced fatty acid usage under stress, which affected muscle performance and exercise dynamics.
Results

Muscle-specific deletion of Mcu impairs acute mitochondrial Ca
2+ influx. Constitutive impairment of MCU function in Mcu global gene-deleted mice caused a significant reduction in body weight and muscle fiber size (13) . To explore the specific role of MCU-mediated mitochondrial Ca 2+ signaling in skeletal muscle function, we developed a skeletal muscle-specific loss-of-function model in which Mcu-loxP-targeted mice (Mcu fl/fl ) were crossed to gene-targeted mice expressing a Cre recombinase under the control of the Myod locus (MyoD-Cre; Figure 1A ) (17 Figure 1D and Supplemental Figure 1B) . Additionally, mitochondrial Ca 2+ uptake was assessed in purified skeletal muscle mitochondria isolated from 2-month-old animals using the Ca Figure 1 , D and E). Interestingly, loss of Mcu with MyoD-Cre throughout development did not affect body weight, muscle weights, or fiber cross-sectional areas versus controls at 4 months of age ( Figure 1 , F-H), nor did it negatively affect skeletal muscle histology or mitochondrial ultrastructure by electron microscopy ( Figure 1, I and J, and Supplemental Figure 2 ). In support of these observations, Western blot analysis of the activation states of Akt and GSK3α/β revealed no alterations in the phosphorylation status of these growth-regulating kinases in the absence of Mcu, further suggesting that MCU does not directly control muscle growth (Supplemental Figure 3) . Figure 2A and ref. 18 ). Tamoxifen chow was administered to 8-week-old adult mice for 4 weeks to mediate Mcu deletion, after which mice were analyzed at 28 weeks of age ( Figure 2B ). This long time point for subsequent analysis was needed because of low turnover of MCU protein from mitochondria in vivo, as we observed previously in the heart (14) . Following this dosing regimen, MCU protein levels were reduced by greater than 90% in 2+ uptake as compared with control animals ( Figure 2E ), yet this impairment in mitochondrial Ca 2+ influx had no impact on muscle weights and tissue integrity assessed by histology (Figure 2, D and F) .
Adeno-associated virus serotype 9 expressing Cre recombinase (AAV9-Cre) was also directly injected into the tibialis anterior (TA) muscle of 6-week-old Mcu fl/fl animals as another means of mediating adult muscle-specific Mcu deletion, which was compared with AAV9 expressing GFP (AAV9-GFP) ( Figure 2G ). MCU protein levels were reduced in TA muscle lysates of AAV9-Cre-transduced animals compared with AAV9-GFP controls at 8 weeks following viral transduction ( Figure 2H ). Yet no changes in TA muscle weight were observed, nor was tissue pathology present ( Figure 2 , I and J). Collectively, these results suggest that loss of MCU-dependent Ca 2+ signaling was not associated with a significant change in skeletal muscle growth or histologically assessed structure.
MCU Ca 2+ signaling controls acute mitochondrial energy production. Heart-specific deletion of Mcu caused a deficit in acute exercise performance in mice, as well as inhibition of β-adrenergic-stimulated respiration in isolated cardiomyocytes (14) . To examine whether MCU plays a similar role in skeletal muscle, respiration rates in isolated muscle mitochondria were first examined under baseline conditions and conditions Figure  3C ). However, in a prolonged acclimatization running protocol, where animals were allowed to transition from rest to running over 30 minutes and then challenged to complete 20 minutes at maximum speed (Figure 3D ), there were no differences in exercise capacity between the Mcu-deleted and control groups ( Figure  3E ). These results suggest that loss of Mcu in skeletal muscle impairs acute Ca 2+ -stimulated mitochondrial controls under exercise conditions revealed a significant increase in tissue lactate, supporting impaired glucose oxidation. Citrate, glutamine, glycine, valine, and phenylalanine levels were also elevated, suggesting alterations in substrate entry into the TCA cycle with associated changes in metabolite flux (Supplemental Table) , which may underlie the exercise phenotype observed in Mcu-deficient animals ( Figure 3C ). Figure 4I ). These results suggest a partial inhibition of baseline and exercise-induced glucose oxidation. Importantly, malonyl-CoA, an inhibitor of carnitine palmitoyltransferase 1, a key enzyme regulating fatty acid entry into the β-oxidation pathway, was significantly reduced in Mcu fl/fl-MyoD-Cre exercised muscle as compared with controls with exercise but not at baseline, further supporting preferential fatty acid metabolism in Mcu-deficient muscle ( Figure 4J and Supplemental Figure 4D ). No differences in total muscle glycogen were observed (Supplemental Figure 4E) .
Finally, while body weights were unchanged in Mcu fl/fl-MyoD-Cre versus Mcu fl/fl controls as they aged to 7 months, Mcu deletion was associated with a significant decrease in total fat mass as measured by magnetic resonance imaging (Supplemental Figure 5, A-C) , suggesting that MCU regulation of muscle metabolic substrate selection affects the total metabolic profile of these mice and likely greater total energy usage. Because fat mass is a relatively minor component of the total animal weight, total body mass was not significantly different between the 2 groups, despite the mild but significant reduction in fat mass with aging.
Discussion
Mitochondrial Ca 2+ signaling serves as an important link between contraction of the heart and energetics because acute Ca 2+ entry through the MCU confers fast, dynamic regulation of mitochondrial energy output (14, 15) . Similar to the heart, the MCU in skeletal muscle also mediates mitochondrial Ca 2+ transport, which, by using an shRNA approach in mice or in a fully germline deficient mouse model, was suggested to influence muscle function and growth (13, 16) . Here, we used 3 muscle-specific genetic approaches in the mouse to specifically address the functional role of MCU, which is a critical consideration because fully germline deficient Mcu -/-mice are known to have compensatory changes that mask some functions of MCU (13, 16) . We demonstrated that skeletal muscle-specific deletion of Mcu during development or adulthood each resulted in inhibited acute mitochondrial Ca 2+ uptake. Contrary to a previous report where viral-mediated shRNA knock down of MCU in skeletal muscle caused muscle atrophy (16), our study revealed that genetic ablation of Mcu at 3 stages of development (fetal, postnatal, and adult) had no significant impact on overall muscle growth. However, we observed that MCU and mitochondrial Ca 2+ are intimately linked to muscle metabolism because Mcu deletion caused an impairment in mitochondrial energy production stimulated by Ca 2+ , alterations in TCA cycle substrate flux, and a shift toward fatty acid metabolism that ultimately resulted in a mild but significant reduction of total body fat mass with aging.
Skeletal muscle is a metabolic omnivore with the capacity to use both glucose and fatty acids as fuel sources (19) . It has long been known that preferential usage of glucose versus fatty acids can be influenced by a number of factors, including energetic demand (exercise) and nutrient availability (obesity and diabetes) (20) . In this study, we observed that deletion of Mcu specifically in skeletal muscle inhibited acute mitochondrial Ca 2+ influx and resulted in 2 seemingly incongruent physiological phenotypes. Animals with skeletal muscle-specific deletion of Mcu displayed a deficit in running capacity in a sprinting protocol, suggesting impaired muscle function ( Figure 3C ), yet these animals displayed enhanced muscle function and metabolic recovery during fatigue (Figure 4, A and F) . Indirect calorimetry during this run-to-exhaustion and recovery regimen revealed 2 phases of substrate usage. During the run-to-exhaustion phase, mice displayed an increased reliance on glucose metabolism, whereas during the recovery phase, fatty acid metabolism predominated ( Figure 4D ) and mice with muscle-specific deletion of Mcu recovered more quickly ( Figure 4F ). Analysis of oxygen consumption in isolated muscle fibers revealed that loss of Mcu led to an enhanced ability to respire when fatty acids were used as substrates. Similarly, alterations in PDH phosphorylation and malonyl-CoA levels were consistent with a shift toward fatty acid oxidation when Mcu is deleted from muscle. However, to truly prove that skeletal muscle from Mcu-deficient mice preferentially uses fatty acids in vivo under working conditions, NMR spectroscopy would be needed.
The loss of MCU produced a compensatory upregulation in fatty acid usage, as shown by a number of direct and indirect assays in Figure 4 . For example, acute maximal exercise of skeletal muscle in mammals typically involves the usage of all possible metabolic pathways and substrates, both mitochondrial-dependent and -independent, and a defect in any of these components would likely compromise maximal performance. The acute uptake of Ca 2+ into mitochondria in the immediate phase of exercise stimulates TCA cycle dehydrogenases, the electron transport chain, and ATP synthase to rapidly augment high-energy phosphate production (21) .
Under these acute conditions, Mcu-deleted mice showed a significant defect in performance on the treadmill, presumably because they were not able to rapidly augment mitochondrial fatty acid and glucose oxidation, yet glycolysis and lactate production, which are major aspects of anaerobic sprinting, still provide much of the capacity. Indeed, the increased lactate seen after exercise in the Mcu-null mice (Supplemental Table) may be evidence of reduced glucose oxidation during exercise that would normally consume glycolysis-derived pyruvate/lactate. However, warming up the mice for 30 minutes at lower speeds allows the mitochondria in skeletal muscle to presumably still accumulate Ca 2+ through other uptake processes, as we showed previously with Mcu deletion from the heart (14) . Because of unknown compensatory augmentations in skeletal muscle metabolism in the absence of MCU, gradual mitochondrial Ca 2+ loading through alternative pathways now permitted the mice to sustain a more robust exercise regimen thereafter ( Figure 3E ) and even deal more effectively with fatigue ( Figure 4A ). We hypothesize that MCU functions as an evolutionary adaptive gene that underlies rapid induction of metabolic output to presumably allow for reduced baseline homeostatic energy usage. In its absence there appears to be a compensation that permits greater fatty acid usage, maybe because this substrate is less reliant on mitochondrial Ca 2+ load compared with glucose oxidation, which is regulated by PDH activity, a direct target of mitochondrial Ca 2+ signaling. Also, in the absence of MCU there appears to be less mitochondrial glucose oxidation or increased glycolysis, although total glucose usage is unaffected (Figure 4G ), contributing to the observed increase in lactate, as seen in other systems (22) . However, to really know these relationships with certainty, in vivo substrate usage profiling with NMR spectroscopy would be needed at rest, during sprinting, and with sustained exercise.
In summary, we conclude that deletion of Mcu in skeletal muscle causes a loss in metabolic flexibility with an enhanced reliance on fatty acid metabolism, which is unmasked under conditions of prolonged stress and aging. Because skeletal muscle is the largest organ in the body with the greatest impact on whole body energy expenditure, this work also highlights a new role for MCU in the control of systemic metabolism.
Methods
Animals. Mcu
fl/fl gene-targeted mice were generated previously (14) . fl/fl-Ska-MCM animals was induced by feeding 8-week-old mice tamoxifen citrate mouse chow (400 mg/kg; Harlan Laboratories) for 4 weeks. All animal experiments were approved and performed in accordance with Cincinnati Children's Hospital Medical Center's and Emory University's IACUCs. Mice were randomly assigned to experimental groups, although because they were genetically identical for each of the groups and matched for age and sex ratio, randomization is a rather unimportant consideration. Both male and female mice were used in an equal ratio, and no sex-specific differences were observed. Experiments with mice were performed in a blinded manner where possible.
Adeno-associated viruses and direct muscle injections. AAV9-Cre and AAV9-GFP were purchased from Vigene Biosciences. The TA muscle of 8-week-old Mcu fl/fl animals was injected with 50 μl sterile PBS containing 1 × 10 12 viral particles using a 30.5-gauge needle. Muscle was harvested 8 weeks following viral transduction. The muscle from one leg was flash frozen for immunoblotting, and the muscle from the other leg was processed for histology. Histological analyses. Muscles were harvested, fixed in 10% formalin, and embedded in paraffin. Then, 5-μm tissue sections were prepared and stained with H&E. The myofiber cross-sectional area was measured using NIH Image J software. For transmission electron microscopy, quadriceps muscle was harvested, fixed in 3.5% glutaraldehyde and 0.15% sucrose in 0.1 M sodium cacodylate, pH 7.4, postfixed in 1% OsO 4, dehydrated, and embedded in epoxy resin, as previously described (23) . Imaging was performed using a Hitachi 7600 electron microscope.
Mitochondrial isolation and Ca 2+ measurements. Calcium uptake in isolated skeletal muscle mitochondria was performed using a Calcium Green-5N assay (Molecular Probes) (14) . Skeletal muscle mitochondria were isolated by differential centrifugation in MS-EGTA buffer (225 mM mannitol, 75 mM sucrose, 5 mM HEPES, and 1 mM EGTA, pH 7.4), and the Ca 2+ uptake assay was conducted as previously described (14) . Briefly, mitochondria were suspended in buffer containing 125 mM KCl, 20 mM HEPES, 2 mM MgCl 2 , 2 mM potassium phosphate, 40 μM EGTA (pH 7.2), 500 μM Calcium Green-5N (Molecular Probes), 7 mM pyruvate, and 1 mM malate. Mitochondria were challenged with additions of 10 μM CaCl 2 . Calcium Green-5N fluorescence was monitored using a Synergy 2 microplate reader (BioTek).
For mitochondrial Ca 2+ measurements in intact myofibers, FDB muscle fibers were isolated as described previously (24) . For baseline and permeabilized mitochondrial Ca 2+ measurements, isolated FDB fibers were incubated with 5 μM Rhod-2 AM (Thermo Fisher Scientific) for 60 minutes at room temperature (25) . Fibers were treated with Rhod-2 AM in suspension for 45 minutes before they were attached to glass-bottom culture dishes (MatTek Corporation) precoated with laminin (Thermo Fisher Scientific) and incubated for an additional 15 minutes. Fibers were then given a 30-minute room temperature de-esterification wash to remove unincorporated dye. For baseline mitochondrial Ca 2+ measurements, myofibers were then imaged for Rhod-2 fluorescence on a Nikon A1R LUN-V inverted confocal microscope (561 nm excitation/600 nm detection/×60 objective) at room temperature (22°C-24°C). Analysis was conducted using Nikon Elements software. Individual groups of axial mitochondria were manually gated to avoid off-target XY fluorescence, and mean baseline Rhod-2 intensity was calculated by averaging 5 mitochondrial regions of interest per myofiber. For permeabilization, washed myofibers were incubated with medium containing 50 μg/ml saponin (Fluka) for 30 minutes at room temperature. Saponin was then washed out and the permeabilized myofibers were incubated in supplemented intracellular buffer (26) . Permeabilized myofibers were then imaged as above in a time-lapse experiment and challenged with the single addition of buffer containing 20 μM CaCl 2 . Five to 10 axial mitochondria regions of interest, as described above, were used to calculate average myofiber Rhod-2 intensity throughout the time lapse. Rhod-2 fluorescence values were normalized to initial fluorescence values for stimulated Ca 2+ uptake experiments. For measurements of cytosolic Ca 2+ transients in intact FDB myofibers, fibers were loaded with 10 μM Fluo-4 AM (Molecular Probes), for 20 minutes followed by 20 minutes of dye de-esterification in Ca
2+
-free Tyrode's solution. Ca 2+ transient measurements were acquired from FDB fibers bathed in Tyrode's solution containing 2 mM CaCl 2 . Electrical field stimulation was applied using an IonOptix MyoPacer Cell Stimulator (1 Hz, 10 ms duration, 32 V), and Fluo-4 was imaged by laser scanning confocal microscopy (Olympus FV1000, 488 nm excitation and 515 ± 15 nm emission). All experiments were performed at room temperature, and data were analyzed using Olympus FV1000 FluoView microscope software and Clampfit.
Mitochondrial respiration. Oxygen consumption was measured on isolated skeletal muscle mitochondria using an Oxygraph Plus instrument (Hansatech) as described previously (13) . Mitochondrial oxygen consumption was measured in respiration buffer containing 120 mM KCl, 5 mM MOPS, 0.1 mM EGTA, 5 mM KH 2 PO 4 , 0.2% BSA, 10 mM glutamate, and 2 mM malate. ADP-stimulated respiration was initiated with 0.5 mM ADP, uncoupled respiration was initiated with 5 μM FCCP, and Ca 2+ -stimulated respiration was initiated with 0.1 mM CaCl 2 .
Oxygen consumption was also measured in freshly isolated myofibers from FDB muscles. For this procedure FDB muscle was first incubated in 5 mL DMEM (GE Healthcare Lifescience) containing 0.2% collagenase type I (Sigma-Aldrich), 1 mM sodium pyruvate (Sigma-Aldrich), and 1% penicillin/streptomycin (Thermo Fisher Scientific) in a 35-mm cell culture dish (Denville) (27) . Muscles were placed at 37°C in an incubator with 5% CO 2 (Thermo Fisher Scientific) and digested for 75 to 90 minutes. Then the muscles were triturated using large-bore glass pipettes under the Olympus SZH10 stereo microscope until individual fibers were visible in the dish. The isolated fibers were washed several times in 60-mm cell culture dishes (Denville) containing DMEM supplemented with 20% FBS (VWR Life Science) and 10% horse serum (Gibco). FDB fibers were then placed in horse serum-precoated, 12-well cell culture dishes (Denville) and incubated at 37°C in an incubator with 5% CO 2 (Thermo Fisher Scientific) for 30 minutes. Culturing medium was changed to assay medium (28) containing either 10 mM glucose or 200 μM BSA-conjugated palmitate (Sigma-Aldrich) and incubated at 37°C with 5% CO 2 (Thermo Fisher Scientific) for 2 hours. Fiber number per well was counted, and oxygen consumption rate was measured using an Oxygraph Plus instrument (Hansatech). Oxygen consumption rate was normalized to fiber number.
Western blot analysis. Total muscle protein extracts were prepared from quadriceps and TA muscles by homogenization in radioimmunoprecipitation assay (RIPA) buffer supplemented with protease inhibitors (Roche) and phosphatase inhibitors (Calbiochem). Mitochondrial protein extracts were prepared by solubilizing isolated muscle mitochondria with the same RIPA buffer. Proteins were resolved on SDS PAGE gels, transferred to polyvinylidene fluoride (PVDF) membranes (MilliporeSigma), and immunodetected with antibodies. Antibodies used in this study are MCU (Cell Signaling Technology, #14997; 1:1,000), VDAC/Porin (Abcam; Ab14734; 1:1,000), GAPDH (Fitzgerald, 10R-G109A; 1:5,000), p-PDHE1α (Ser293) (Novus Biologicals, NB110-93479; 1:500), PDHE1α (Abcam, Ab110330; 1:500), p-Akt (Ser473) (Cell Signaling Technology, #4051S; 1:1,000), Akt (Cell Signaling, #9272S; 1:1,000), p-GSK3α/β (Cell Signaling Technology, #8566S; 1:1,000), and GSK3α/β (Cell Signaling Technology, #5676; 1:1,000).
Muscle functional analyses and treadmill running. For muscle fatigue experiments, mice were anesthetized with an intraperitoneal injection of pentobarbital, a midline incision running from the ankle to the thigh was created, and the skin and fascia were gently removed to expose the TA muscle. The mouse was then placed in a supine position on the muscle testing apparatus, and the leg was immobilized by securing it with thumbscrews set at the distal femur in a custom rig (Aurora Scientific). The distal muscle tendon junction was tied to a small plastic ring, and the distal tendon was resected and the TA gently sliced off the tibia and secured to a servomotor (Aurora Scientific, 305C) using a plastic ring. Two intramuscular electrodes were placed on either side of the peroneal nerve, and stimulation voltages and optimal muscle length (L 0 ) were determined and then adjusted to produce maximal isometric force (P 0 ) at a stimulation frequency of 150 Hz. Five consecutive isometric contractions were averaged as a measure of the maximal specific tension. A 2-minute rest period was taken between contractions. Once P 0 was determined, the TA was subjected to a fatigue protocol in which the muscle experienced 3 bouts of isometric tetanic contractions at a stimulation frequency of 150 Hz and maintained for 45 seconds followed by a single twitch. A 2-minute rest period occurred between every fatigue protocol, and force values were normalized to the muscle's physiological cross-sectional area. Metrics of maximal specific force and relaxation kinetics were determined using MATLAB analysis of the raw force-time transients. For the acute and prolonged acclimatization running protocols, enforced running was performed using an Omni-Pacer LC4/M treadmill (Columbus Instruments International), as detailed in Figure 3 .
Indirect calorimetry and treadmill running. Metabolic rates were measured at rest and during exercise as described previously (29) . Measurements were taken in metabolic chambers at 24°C with or without food but with free access to water. The resting oxygen consumption and carbon dioxide production rates (VO 2 and VCO 2 , respectively) were measured every 8 minutes using the Oxymax Plus system (Columbus Instruments International) for 24 hours. Fresh air was delivered into chambers with an electric pump. To monitor energy expenditure during exercise, a sealed motorized treadmill was used. The treadmill had adjustable speed and inclination and was equipped with a small electric shock-delivering grid that was used in the training regimens so that mice were used to the running protocol. Electric shock intensity was set to 1 mA and inclination was set to 5%. Gas samples from the treadmill chamber were collected every 15 seconds and analyzed by the Oxymax Plus system for measurement of VO 2 and VCO 2 . For the actual experiment, mice experienced acclimation at 3 m/min for 15 minutes and then moved over the next 7 minutes to 50 m/min and maintained this speed for 3 minutes as full exertion, followed thereafter by 0 m/min for 25 minutes as recovery. For the data shown in Figure 4 , D-F, conditions were such that all genotypes of mice ran the same exact same time and distance in the protocol, and because body weights were similar, each group of mice performed the same total work. RER was calculated as VO 2 /VCO 2 with CLAMS data eXamination Tool (Columbus Instruments International).
Metabolic profiling and malonyl-CoA measurements. For skeletal muscle metabolomics profiling, 2-monthold mice were run to exhaustion, quadriceps muscle was harvested 2 minutes after exhaustion, and muscles were snap-frozen in liquid nitrogen. Metabolite extraction, acquisition of one-dimensional 1 H NMR spectra using a Bruker Avance II 600 MHz spectrometer, and data analyses were conducted by the Cincinnati Children's Hospital NMR-based Metabolomics Core. Briefly, muscles were homogenized and incubated with methanol/chloroform/water mix to obtain polar metabolites. Vacuum centrifugation was performed to achieve dried metabolites, which were resuspended for NMR spectroscopy acquisition. To measure malonyl-CoA, 2-month-old mice were run to exhaustion and quadriceps harvested and snap-frozen. Additionally, quadriceps from 2-month-old mice at baseline were collected. Muscles were homogenized in ice-cold PBS and subjected to 2 freeze-thaw cycles, and cleared lysates were prepared by centrifugation. Malonyl-CoA levels were subsequently measured using a malonyl-CoA ELISA Kit (MyBioSource).
MRI body composition analysis. Fat mass and lean mass of mice were measured with EchoMRI body composition analyzer from EchoMRI. The mouse was placed in a special plastic holder with restricted movement, and the holder was inserted in the magnet for MRI measurement. Duplicate measurements were performed for each animal during 1 run. Mice were examined every month starting at 1 month of age.
PDH activity assay. PDH activity was measured with a PDH combo microplate assay kit (Abcam). Quadriceps from mice at 2 to 3 months of age were collected and frozen in liquid nitrogen. Sample preparations as well as measurements were performed as outlined in the kit instructions.
Muscle glycogen measurement. Muscle glycogen content was measured using the Glycogen Assay Kit (Sigma-Aldrich). TA muscles were collected from mice at 2 to 3 months of age and frozen in liquid nitrogen for tissue processing. Muscles were homogenized in deionized water on ice. Homogenates were boiled for 5 minutes and centrifuged at 13,000 g for 5 minutes. Supernatants were used for glycogen measurements, and samples were measured according to the product protocol.
Statistics. All results are presented as mean ± SEM or SD. Statistical significance between 2 groups was determined by 2-tailed Student's t-test and P < 0.05 was considered significant. One-way ANOVA followed by Dunnett's multiple comparisons test were used to determine statistical significance among 3 groups and P < 0.05 was considered significant. For stimulated mitochondrial Ca 2+ uptake in permeabilized myofibers, 2-way ANOVA followed by Bonferroni's multiple comparisons test was used.
Study approval. All experiments involving mice were approved by the IACUC at Cincinnati Children's Hospital Medical Center, approval number IACUC 2016-0069.
Author contributions
JDM and JQK wrote the manuscript. JQK, JH, MJB, JGB, JAS, JTM, YCJ, KS, and NG performed experiments. JDM, JD, DMB, and ZK provided experimental oversight, analyzed the data, and helped design the study.
